Heparanase activates the syndecan-syntenin-ALIX exosome pathway

Cell Research

Volumn 25, Issue 4, 2015, Pages 412-428

  Roucourt, Bart ^a,b   Meeussen, Sofie ^a,b   Bao, Jie ^a,b   Zimmermann, Pascale ^b,c,d   David, Guido ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSERM   (France)

Author keywords

Exosomal cargo; Exosome biogenesis; Heparan sulfate; Heparanase; Syndecan; Syntenin

Indexed keywords

MAMMALIA;

BETA GLUCURONIDASE; CALCIUM BINDING PROTEIN; CELL CYCLE PROTEIN; ESCRT PROTEIN; FLOTILLINS; HEPARAN SULFATE; HEPARANASE; MEMBRANE PROTEIN; PDCD6IP PROTEIN, HUMAN; SYNDECAN; SYNTENIN;

BIOSYNTHESIS; EXOSOME; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; SIGNAL TRANSDUCTION;

CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; EXOSOMES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLUCURONIDASE; HEPARITIN SULFATE; HUMANS; MCF-7 CELLS; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; SYNDECANS; SYNTENINS;

EID: 84926524813     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2015.29     Document Type: Article

References (40)

1. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200:373-383.
2. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-659.
3. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-1476.
4. Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996; 183:1161-1172.
5. Thery C, Duban L, Segura E, Veron P, Lantz O, Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002; 3:1156-1162.
6. Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18:883-891.
7. Luga V, Zhang L, Viloria-Petit AM, et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151:1542-1556.
8. Raiborg C, Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009; 458:445-452.
9. Henne WM, Buchkovich NJ, Emr SD. The ESCRT pathway. Dev Cell 2011; 21:77-91.
10. Wollert T, Hurley JH. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 2010; 464:864-869.
11. Hurley JH, Hanson PI. Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol 2010; 11:556-566.
12. Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319:1244-1247.
13. Ghossoub R, Lembo F, Rubio A, et al. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun 2014; 5:3477.
14. Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012; 14:677-685.
15. Hurley JH, Odorizzi G. Get on the exosome bus with ALIX. Nat Cell Biol 2012; 14:654-655.
16. Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999; 5:793-802.
17. Kelly T, Miao HQ, Yang Y, et al. High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res 2003; 63:8749-8756.
18. Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 2004; 96:1219-1230.
19. Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 2006; 38:2018-2039.
20. Vreys V, Delande N, Zhang Z, et al. Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans. J Biol Chem 2005; 280:33141-33148.
21. Zetser A, Levy-Adam F, Kaplan V, et al. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 2004; 117:2249-2258.
22. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N. Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 2004; 279:23536-23541.
23. Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res 2006; 66:1455-1463.
24. Fux L, Feibish N, Cohen-Kaplan V, et al. Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling. Cancer Res 2009; 69:1758-1767.
25. Thompson CA, Purushothaman A, Ramani VC, Vlodavsky I, Sanderson RD. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem 2013; 288:10093-10099.
26. Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci USA 2013; 110:17380-17385.
27. Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol 2011; 3:pii: a004952.
28. Vanlandingham PA, Ceresa BP. Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration. J Biol Chem 2009; 284:12110-12124.
29. Raiborg C, Bremnes B, Mehlum A, et al. FYVE and coiledcoil domains determine the specific localisation of Hrs to early endosomes. J Cell Sci 2001; 114:2255-2263.
30. Shteingauz A, Ilan N, Vlodavsky I. Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and alpha-actinin. Cell Mol Life Sci 2014; 71:4457-4470.
31. Zimmermann P, Tomatis D, Rosas M, et al. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. Mol Biol Cell 2001; 12:339-350.
32. Liu D, Shriver Z, Venkataraman G, El Shabrawi Y, Sasisekharan R. Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc Natl Acad Sci USA 2002; 99:568-573.
33. Peterson SB, Liu J. Multi-faceted substrate specificity of heparanase. Matrix Biol 2013; 32:223-227.
34. Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP, Leis J. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol 1994; 68:6605-6618.
35. David G, Lories V, Decock B, Marynen P, Cassiman JJ, Van den Berghe H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol 1990; 111:3165-3176.
36. Grootjans JJ, Zimmermann P, Reekmans G, et al. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci USA 1997; 94:13683-13688.
37. David G, van der Schueren B, Marynen P, Cassiman JJ, van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992; 118:961-969.
38. de Boeck H, Lories V, David G, Cassiman JJ, van den Berghe H. Identification of a 64 kDa heparan sulphate proteoglycan core protein from human lung fibroblast plasma membranes with a monoclonal antibody. Biochem J 1987; 247:765-771.
39. Lories V, Cassiman JJ, Van den Berghe H, David G. Multiple distinct membrane heparan sulfate proteoglycans in human lung fibroblasts. J Biol Chem 1989; 264:7009-7016.
40. Zimmermann P, Meerschaert K, Reekmans G, et al. PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane. Mol Cell 2002; 9:1215-1225.